Skip to content

AIACT Kit

by Sienco, Inc.

510(k) K032952

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK032952 Date12 Dec 2003ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
JBP
Device class
Class II
Regulation
21 CFR Part 864.7140
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AIACT Kit is an in vitro diagnostic test for use with Sonoclot® Analyzer Systems. It is a celite/clay blend activated test that provides quantitative ACT and Clot Rate results for high dose heparin management.

The kit is intended for use with native whole blood and citrated whole blood, and is not affected by aprotinin. It includes cuvettes, probes, instructions for use, and reference plasma quality control. The device is FDA 510(k) cleared with product code JBP.

Devices cleared under K032952

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K032952
UDI-DISize and differences
Sonoclot® aiACT Kit 800-0442
SIENCO, INC.
800-0442 / 800-0442B55880004421 —On the market

Similar devices

Other devices filed under FDA product code JBP (Activated Whole Blood Clotting Time).

Other devices from Sienco, Inc.

See all devices from Sienco, Inc. →